Phosphoproteomics identifies oncogenic ras signaling targets and their involvement in lung adenocarcinomas

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Sudhir, Putty Reddy ^a,e   Hsu, Chia Lang ^b   Wang, Mei Jung ^a   Wang, Yi Ting ^c   Chen, Yu Ju ^c   Sung, Ting Yi ^d   Hsu, Wen Lian ^d   Yang, Ueng Cheng ^b   Chen, Jeou Yuan ^a,b  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c INSTITUTE OF CHEMISTRY   (Taiwan)

^d INSTITUTE OF INFORMATION SCIENCE   (Taiwan)

^e GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LUNG ADENOCARCINOMA; MOLECULAR MECHANICS; ONCOGENE RAS; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEOMICS; RNA PROCESSING; SIGNAL TRANSDUCTION; UPREGULATION; ADENOCARCINOMA; BRONCHUS; CELL LINE; CHEMISTRY; EPITHELIUM CELL; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

PHOSPHOPEPTIDE; PHOSPHOPROTEIN;

ADENOCARCINOMA; AMINO ACID MOTIFS; AMINO ACID SEQUENCE; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; EPITHELIAL CELLS; GENES, RAS; HUMANS; LUNG NEOPLASMS; MOLECULAR SEQUENCE DATA; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 79957540957     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020199     Document Type: Article

References (34)

1. Downward J, (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3: 11-22.
2. Karnoub AE, Weinberg RA, (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9: 517-531.
3. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, et al. (2008) Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455: 1069-1075.
4. Malumbres M, Barbacid M, (2003) RAS oncogenes: the first 30 years. Nat Rev Cancer 3: 459-465.
5. Schreiber TB, Mausbacher N, Breitkopf SB, Grundner-Culemann K, Daub H, (2008) Quantitative phosphoproteomics--an emerging key technology in signal-transduction research. Proteomics 8: 4416-4432.
6. Guha U, Chaerkady R, Marimuthu A, Patterson AS, Kashyap MK, et al. (2008) Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc Natl Acad Sci U S A 105: 14112-14117.
7. Mann M, (2006) Functional and quantitative proteomics using SILAC. Nat Rev Mol Cell Biol 7: 952-958.
8. Cutillas PR, Vanhaesebroeck B, (2007) Quantitative profile of five murine core proteomes using label-free functional proteomics. Mol Cell Proteomics 6: 1560-1573.
9. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-9034.
10. Sato M, Vaughan MB, Girard L, Peyton M, Lee W, et al. (2006) Multiple oncogenic changes (K-RAS(V12), p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells. Cancer Res 66: 2116-2128.
11. Lee JL, Wang MJ, Sudhir PR, Chen JY, (2008) CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. Molecular and Cellular Biology 28: 5710-5723.
12. Lu X, Zhu H, (2005) Tube-gel digestion: a novel proteomic approach for high throughput analysis of membrane proteins. Mol Cell Proteomics 4: 1948-1958.
13. Tsai CF, Wang YT, Chen YR, Lai CY, Lin PY, et al. (2008) Immobilized metal affinity chromatography revisited: pH/acid control toward high selectivity in phosphoproteomics. J Proteome Res 7: 4058-4069.
14. Tsou CC, Tsai CF, Tsui YH, Sudhir PR, Wang YT, et al. (2010) IDEAL-Q, an automated tool for label-free quantitation analysis using an efficient peptide alignment approach and spectral data validation. Mol Cell Proteomics 9: 131-144.
15. Lee E, Chuang HY, Kim JW, Ideker T, Lee D, (2008) Inferring pathway activity toward precise disease classification. PLoS Comput Biol 4: e1000217.
16. Wilbur WJ, Yang Y, (1996) An analysis of statistical term strength and its use in the indexing and retrieval of molecular biology texts. Computers in Biology and Medicine 26: 209-222.
17. Popescu M, Keller JM, Mitchell JA, (2006) Fuzzy measures on the Gene Ontology for gene product similarity. IEEE/ACM Trans Comput Biol Bioinform 3: 263-274.
18. Wu H, Tein Y, Chen C, (2009) GAP: A graphical environment for matrix visualization and cluster analysis. Computational Statistics & Data Analysis 54: 767-778.
19. Schwartz D, Gygi SP, (2005) An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets. Nature Biotechnology 23: 1391-1398.
20. Linding R, Jensen LJ, Ostheimer GJ, van Vugt MA, Jorgensen C, et al. (2007) Systematic discovery of in vivo phosphorylation networks. Cell 129: 1415-1426.
21. Miller ML, Jensen LJ, Diella F, Jorgensen C, Tinti M, et al. (2008) Linear motif atlas for phosphorylation-dependent signaling. Sci Signal 1: ra2.
22. Van Hoof D, Munoz J, Braam SR, Pinkse MW, Linding R, et al. (2009) Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 5: 214-226.
23. Palmer RH, Ridden J, Parker PJ, (1994) Identification of multiple, novel, protein kinase C-related gene products. FEBS Letters 356: 5-8.
24. Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, et al. (2000) Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. Journal of Biological Chemistry 275: 36108-36115.
25. Castro-Rivera E, Ran S, Brekken RA, Minna JD, (2008) Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res 68: 8295-8303.
26. Kosako H, Yamaguchi N, Aranami C, Ushiyama M, Kose S, et al. (2009) Phosphoproteomics reveals new ERK MAP kinase targets and links ERK to nucleoporin-mediated nuclear transport. Nat Struct Mol Biol 16: 1026-1035.
27. Old WM, Shabb JB, Houel S, Wang H, Couts KL, et al. (2009) Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Molecular Cell 34: 115-131.
28. Yoon S, Seger R, (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24: 21-44.
29. Riely GJ, Marks J, Pao W, (2009) KRAS mutations in non-small cell lung cancer. Proc Am Thorac Soc 6: 201-205.
30. Haigis KM, Kendall KR, Wang Y, Cheung A, Haigis MC, et al. (2008) Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nature Genetics 40: 600-608.
31. Voice JK, Klemke RL, Le A, Jackson JH, (1999) Four human ras homologs differ in their abilities to activate Raf-1, induce transformation, and stimulate cell motility. Journal of Biological Chemistry 274: 17164-17170.
32. Persidis A, (1998) Signal transduction as a drug-discovery platform. Nature Biotechnology 16: 1082-1083.
33. Lawlor K, Nazarian A, Lacomis L, Tempst P, Villanueva J, (2009) Pathway-based biomarker search by high-throughput proteomics profiling of secretomes. J Proteome Res 8: 1489-1503.
34. Zubarev RA, Nielsen ML, Fung EM, Savitski MM, Kel-Margoulis O, et al. (2008) Identification of dominant signaling pathways from proteomics expression data. J Proteomics 71: 89-96.